Skip to main navigation Skip to search Skip to main content

Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study

  • for the Israeli myeloma study group
  • Tel Aviv Sourasky Medical Center
  • Sheba Medical Center at Tel Hashomer
  • Technion-Israel Institute of Technology
  • Hadassah University Medical Centre
  • Hebrew University of Jerusalem
  • Soroka Medical Center
  • Shaare Zedek Medical Center
  • Meir Hospital Sapir Medical Center
  • Rabin Medical Center Israel
  • Bnai-Zion Medical Center
  • Assuta Ashdod Hospital
  • Ben-Gurion University of the Negev
  • Assaf Harofeh Medical Center
  • Assuta Ramat Ha Hayal Hospital
  • Tel Aviv University

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science